Dr. Aubrey de Grey

Dr. Aubrey de Grey

Company: AgeX Therapeutics

Job title: VP of New Technology Discovery

Bio:

Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) biomedical research charity that performs and funds laboratory research dedicated to combating the aging process. He is also VP of New Technology Discovery at AgeX Therapeutics, a biotechnology startup developing new therapies in the field of biomedical gerontology. In addition, he is Editor-in-Chief of Rejuvenation Research, the world’s highest-impact peer-reviewed journal focused on intervention in aging. He received his BA in computer science and Ph.D. in biology from the University of Cambridge. His research interests encompass the characterisation of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organisations. He is a highly sought-after speaker who gives 40-50 invited talks per year at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public.

Seminars:

Rejuvenation Biotechnology: Addressing Delivery Challenges in Gene & Stem Cell Therapy 9:15 am

Analyzing how regenerative medicine and other new biomedical technologies will eventually be so comprehensive that people will stay truly youthful however long they live Outlining an innovative approach for stem cell delivery for neurodegenerative diseases Exploring gene therapy potential in aging and how to deliver large cargos with very high insertion-site specificityRead more

day: Day Two

Keynote Panel: A Therapeutic Revolution Against Aging – Bridging the Gaps & Opportunities 9:15 am

Exploring what we know and what we still don’t know about the aging process Exploring the targeting of aging as a disease vs. aging as a common factor for different conditions Analyzing the current R&D landscape for anti-aging therapeutics Key challenges in discovery and progression of pipelines Greatest promises for healthspan improvement Addressing and dealing…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.